GoldenGolden
Twentyeight-Seven Therapeutics

Twentyeight-Seven Therapeutics

Twentyeight-Seven is a biomedical startup with a passion for cutting-edge life saving technology.

Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.

Timeline

September 2018
Twentyeight-Seven Therapeutics raises a $65,000,000 series A round from Astellas Venture Management, Johnson & Johnson Innovation – JJDC, Longwood Fund, MPM Capital, Novartis Venture Fund and Vertex Ventures HC.

Funding rounds

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.